Lineage trades at a NAV discount with recovery potential, a 6.1% yield at 64% payout, expanding scale, and catalysts from rates. Read why LINE stock is a buy.
[Stay on top of transportation news: Get TTNews in your inbox.] Temperature-controlled storage and logistics giant Lineage Inc. is seeking to raise as much as $3.85 billion in its initial public ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, ...
Lineage (NASDAQ:LINE), the world's largest REIT for temperature-controlled warehouses, is implementing job cuts amid a slowdown in demand for col-storage space, according to a recent media report.
CARLSBAD, Calif., November 06, 2025--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell ...
Pace Digitek announced a landmark achievement as its material subsidiary, Lineage Power, has received a prestigious order from Bharat Sanchar Nigam (BSNL). This strategic contract, valued at ...
Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. AI rarely fails because of bad models alone. More often it fails ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results